Home » Topics » Disease categories and therapies » Immune

Immune
RSS

CPMP issues positive opinion for E.U. approval of Zenapax

Dec. 2, 1998

U.S. patent issued for Maxim's MaxVax technology

Dec. 2, 1998

Abbott purchases additional La Jolla stock

Dec. 1, 1998

OraVax files IND for colitis vaccine

Nov. 30, 1998

North American Vaccine continues product launch of Certiva in U.S.

Nov. 26, 1998

Positive clinical data supports Siga's unique vaccine delivery system

Nov. 25, 1998

Chiron reports phase II results of novel Meningococcus C vaccine trial

Nov. 24, 1998

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Nov. 23, 1998

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Nov. 23, 1998

SangCya launched in U.S. less than three weeks following approval

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.